Action Point Financial Planning’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
Other funds holding CRSP
Action Point Financial Planning's CRSP Position: Q3 2026 in Review
Action Point Financial Planning sold out of CRISPR Therapeutics (CRSP) in Q3 2026, closing a stake of 45 shares — an estimated $2.46K sold.
Action Point Financial Planning first reported a position in CRSP in Q2 2026 and held it in 1 quarter. The position peaked at $2.46K in Q2 2026. 503 funds tracked by Wall St. Rank hold CRSP as of Q3 2026.
- Action Point Financial Planning reported no remaining CRISPR Therapeutics position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 45 CRISPR Therapeutics shares in Q3 2026, an estimated $2.46K.
- Action Point Financial Planning first reported a position in CRISPR Therapeutics in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's CRISPR Therapeutics position peaked at $2.46K in Q2 2026.
- 503 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.